Cargando…
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance using allele-specific real time quantitative polymerase chain reaction and Sanger sequencing, respectively. A subgroup of 119 patients was further...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709107/ https://www.ncbi.nlm.nih.gov/pubmed/28983055 http://dx.doi.org/10.3324/haematol.2017.172718 |
_version_ | 1783282734794276864 |
---|---|
author | Varettoni, Marzia Zibellini, Silvia Defrancesco, Irene Ferretti, Virginia Valeria Rizzo, Ettore Malcovati, Luca Gallì, Anna Porta, Matteo Giovanni Della Boveri, Emanuela Arcaini, Luca Candido, Chiara Paulli, Marco Cazzola, Mario |
author_facet | Varettoni, Marzia Zibellini, Silvia Defrancesco, Irene Ferretti, Virginia Valeria Rizzo, Ettore Malcovati, Luca Gallì, Anna Porta, Matteo Giovanni Della Boveri, Emanuela Arcaini, Luca Candido, Chiara Paulli, Marco Cazzola, Mario |
author_sort | Varettoni, Marzia |
collection | PubMed |
description | We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance using allele-specific real time quantitative polymerase chain reaction and Sanger sequencing, respectively. A subgroup of 119 patients was further studied with next-generation sequencing of 11 target genes (MYD88, CXCR4, ARID1A, KMT2D, NOTCH2, TP53, PRDM1, CD79B, TRAF3, MYBBP1A, and TNFAIP3). MYD88 (L265P) was found at diagnosis in 91% of patients with Waldenström macroglobulinemia and in 60% of patients with IgM monoclonal gammopathy of undetermined significance using allele-specific polymerase chain reaction analysis. MYD88 mutations other than the classical L265P (V217F, S219C and M232T) were found in four cases by next-generation sequencing. Waldenström macroglobulinemia patients with wild-type MYD88 had a distinct clinical phenotype characterized by less bone marrow infiltration (P=0.01) and more frequent extramedullary involvement (P=0.001) compared to patients with mutated MYD88. Patients with wild-type MYD88 did not show additional mutations in the other target genes. CXCR4 mutations were found by Sanger sequencing in 22% of patients with Waldenström macroglobulinemia. With next-generation sequencing, a CXCR4 mutation was detected in 23% of patients with Waldenström macroglobulinemia and 9% of those with IgM monoclonal gammopathy of undetermined significance. Asymptomatic Waldenström macroglobulinemia patients harboring a CXCR4 mutation had a shorter treatment-free survival (51 months) than that of patients with wild-type CXCR4 (median not reached) (P=0.007). Analysis of variant allele frequencies indicated that CXCR4 mutations were present in the dominant clone in the majority of cases. Recurrent somatic mutations of KMT2D were found in 24% of patients with Waldenström macroglobulinemia and 5% of patients with IgM monoclonal gammopathy of undetermined significance and were primarily subclonal. |
format | Online Article Text |
id | pubmed-5709107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Ferrata Storti Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-57091072017-12-12 Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance Varettoni, Marzia Zibellini, Silvia Defrancesco, Irene Ferretti, Virginia Valeria Rizzo, Ettore Malcovati, Luca Gallì, Anna Porta, Matteo Giovanni Della Boveri, Emanuela Arcaini, Luca Candido, Chiara Paulli, Marco Cazzola, Mario Haematologica Article We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance using allele-specific real time quantitative polymerase chain reaction and Sanger sequencing, respectively. A subgroup of 119 patients was further studied with next-generation sequencing of 11 target genes (MYD88, CXCR4, ARID1A, KMT2D, NOTCH2, TP53, PRDM1, CD79B, TRAF3, MYBBP1A, and TNFAIP3). MYD88 (L265P) was found at diagnosis in 91% of patients with Waldenström macroglobulinemia and in 60% of patients with IgM monoclonal gammopathy of undetermined significance using allele-specific polymerase chain reaction analysis. MYD88 mutations other than the classical L265P (V217F, S219C and M232T) were found in four cases by next-generation sequencing. Waldenström macroglobulinemia patients with wild-type MYD88 had a distinct clinical phenotype characterized by less bone marrow infiltration (P=0.01) and more frequent extramedullary involvement (P=0.001) compared to patients with mutated MYD88. Patients with wild-type MYD88 did not show additional mutations in the other target genes. CXCR4 mutations were found by Sanger sequencing in 22% of patients with Waldenström macroglobulinemia. With next-generation sequencing, a CXCR4 mutation was detected in 23% of patients with Waldenström macroglobulinemia and 9% of those with IgM monoclonal gammopathy of undetermined significance. Asymptomatic Waldenström macroglobulinemia patients harboring a CXCR4 mutation had a shorter treatment-free survival (51 months) than that of patients with wild-type CXCR4 (median not reached) (P=0.007). Analysis of variant allele frequencies indicated that CXCR4 mutations were present in the dominant clone in the majority of cases. Recurrent somatic mutations of KMT2D were found in 24% of patients with Waldenström macroglobulinemia and 5% of patients with IgM monoclonal gammopathy of undetermined significance and were primarily subclonal. Ferrata Storti Foundation 2017-12 /pmc/articles/PMC5709107/ /pubmed/28983055 http://dx.doi.org/10.3324/haematol.2017.172718 Text en Copyright© 2017 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher. |
spellingShingle | Article Varettoni, Marzia Zibellini, Silvia Defrancesco, Irene Ferretti, Virginia Valeria Rizzo, Ettore Malcovati, Luca Gallì, Anna Porta, Matteo Giovanni Della Boveri, Emanuela Arcaini, Luca Candido, Chiara Paulli, Marco Cazzola, Mario Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance |
title | Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance |
title_full | Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance |
title_fullStr | Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance |
title_full_unstemmed | Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance |
title_short | Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance |
title_sort | pattern of somatic mutations in patients with waldenström macroglobulinemia or igm monoclonal gammopathy of undetermined significance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709107/ https://www.ncbi.nlm.nih.gov/pubmed/28983055 http://dx.doi.org/10.3324/haematol.2017.172718 |
work_keys_str_mv | AT varettonimarzia patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT zibellinisilvia patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT defrancescoirene patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT ferrettivirginiavaleria patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT rizzoettore patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT malcovatiluca patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT gallianna patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT portamatteogiovannidella patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT boveriemanuela patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT arcainiluca patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT candidochiara patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT paullimarco patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance AT cazzolamario patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance |